This is definitely not enough data to conclude a 1 in 30,000 figure. And neither does the cited paper conclude this.
https://www.theguardian.com/world/2021/apr/13/astrazeneca-bl...
1. First assume independence, that CVST is unrelated to vaccination.
2. Take any two weeks, you can calculate the expected cases using population background rate because we assume independence.
3. The number is around 1 using Wikipedia data.
4. The observed case number 6 greatly exceeds the expected number based on independence assumption.
5. We conclude that with high probability that our independence assumption is wrong, i.e. there's correlation with high confidence.
You are not sampling a random, normally distributed event over a fixed interval, you are sampling the spacing between two different events where one of them is systemically linked to how you define the population and the interval.
All the observed cases occurred shortly after vaccination, so I’m not sure 3 months is the right divisor to use in your comparison.
Except to the general public this overcautious behavior and resulting media hype raises vaccine suspicions, and will decrease public trust in J&J (and even vaccines in general) as a result. It’s already happening.
https://www.reuters.com/investigates/special-report/johnsona...
Otherwise, there isn't a whole lot of difference between "not real" and "real but so rare as not to matter."
> Cerebral venous sinus thrombosis is rare, with an estimated 3-4 cases per million annual incidence in adults. While it may occur in all age groups, it is most common in the third decade. 75% are female. [0]
[0] https://en.wikipedia.org/wiki/Cerebral_venous_sinus_thrombos....